Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus E protein for a second-generation subunit vaccine

Journal of Virology

Volumn 77, Issue 16, 2003, Pages 8745-8755

  Kojima, Asato ^a   Yasuda, Atsushi ^a,b   Asanuma, Hideki ^a,c   Ishikawa, Toyokazu ^d   Takamizawa, Akihisa ^d   Yasui, Kotaro ^e   Kurata, Takeshi ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b ZEON CORPORATION   (Japan)

^c TOKAI UNIVERSITY   (Japan)

^d Osaka University   (Japan)

^e TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; JAPANESE ENCEPHALITIS VACCINE; RECOMBINANT E VLP ANTIGEN; SIGNAL PEPTIDE; SUBUNIT VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; APOPTOSIS; ARTICLE; CELL DEATH; CELL FUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RABBIT; VIRUS PARTICLE;

ANIMALS; ANTIGENS, VIRAL; CELL LINE; CLONE CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0043210557     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.16.8745-8755.2003     Document Type: Article

References (50)

1. Ashok, M. S., and P. N. Rangarajan. 2001. Evaluation of the potency of BIKEN inactivated Japanese encephalitis vaccine and DNA vaccines in an intracerebral Japanese encephalitis virus challenge model. Vaccine 19:155-157.
2. Berger, E. G. 1997. The Golgi apparatus: from discovery to contemporary studies, p. 1-36. In E. G. Berger and J. Roth (ed.), The Golgi apparatus. Birkhäuser Verlag, Basel, Switzerland.
3. Bolin, S. R., J. F. Ridpath, J. Black, M. Macy, and R. Roblin. 1994. Survey of cell lines in the American Type Culture Collection for bovine viral diarrhea virus. J. Virol. Methods 48:211-221.
4. Cecilia, D., D. A. Gadkari, N. Kedarnath, and S. N. Ghosh. 1988. Epitope mapping of Japanese encephalitis virus envelope protein with monoclonal antibodies against an Indian strain. J. Gen. Virol. 69:2741-2747.
5. Chambers, T. J., A. Nestorowicz, P. W. Mason, and C. M. Rice. 1999. Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. J. Virol. 73:3095-3101.
6. Chambers, T. J., T. F. Tsai, Y. Pervikov, and T. P. Monath. 1997. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting. Vaccine 15:1494-1502.
7. Chang, G. J., A. R. Hunt, and B. Davis. 2000. A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice. J. Virol. 74:4244-4252.
8. Chen, H. W., C. H. Pan, M. Y. Liau, R. Jou, C. J. Tsai, H. J. Wu, Y. L. Lin, and M. H. Tao. 1999. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J. Virol. 73:10137-10145.
9. Endy, T. P., and A. Nisalak. 2002. Japanese encephalitis virus: ecology and epidemiology. Curr. Top. Microbiol. Immunol. 267:11-48.
10. European Agency for the Evaluation of Medical Products. 2002. Note for guidance on the use of bovine serum in the manufacture of human biological medical products. In Committee for Proprietary Medical Products (ed.), Evaluation of medicines for human use. CPMP/BWP/1793/02. London, England.
11. Farquhar, M. G., and H. P. Hauri. 1997. Protein sorting and vesicular traffic in the Golgi apparatus, p. 63-130. In E. G. Berger and J. Roth (ed.), The Golgi apparatus. Birkhäuser Verlag, Basel, Switzerland.
12. Ghosh, S. N., P. S. Sathe, S. A. Sarthi, D. Cecilia, C. N. Dandawate, S. S. Athawale, and U. Pant. 1989. Epitope analysis of strains of Japanese encephalitis virus by monoclonal antibodies. Indian J. Med. Res. 89:368-375.
13. Grachev, V. 1990. World Health Organization attitude concerning the use of continuous cell lines as substrates for production of human virus vaccines. Adv. Biotechnol. Processes 14:37-67.
14. Guirakhoo, F., F. X. Heinz, C. W. Mandl, H. Holzmann, and C. Kunz. 1991. Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J. Gen. Virol. 72:1323-1329.
15. Guirakhoo, F., Z. X. Zhang, T. J. Chambers, S. Delagrave, J. Arroyo, A. D. Barrett, and T. P. Monath. 1999. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Virology 257:363-372.
16. Hanna, J. N., S. A. Ritchie, D. A. Phillips, J. Shield, M. C. Bailey, J. S. Mackenzie, M. Poidinger, B. McCall, and P. J. Mills. 1996. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med. J. Aust. 165:256-260.
17. Harasawa, R., and T. Tomiyama. 1994. Evidence of pestivirus RNA in human virus vaccines. J. Clin. Microbiol. 32:1604-1605.
18. Hasegawa, H., M. Yoshida, T. Fujita, S. Shiosaka, and Y. Kobayashi. 1992. Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice. Virology 191:158-165.
19. Heinz, F. X. 1986. Epitope mapping of flavivirus glycoproteins. Adv. Virus Res. 31:103-168.
20. Heinz, F. X., and S. L. Allison. 2000. Structures and mechanisms in flavivirus fusion. Adv. Virus Res. 55:231-269.
21. Hoshikawa, N., A. Kojima, A. Yasuda, E. Takayashiki, S. Masuko, J. Chiba, T. Sata, and T. Kurata. 1991. Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study. J. Gen. Virol. 67:2509-2517.
22. Hunt, A. R., C. B. Cropp, and G. J. Chang. 2001. A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen. J. Virol. Methods 97:133-149.
23. Igarashi, A. 2002. Control of Japanese encephalitis in Japan: immunization of humans and animals, and vector control. Curr. Top. Microbiol. Immunol. 267:139-152.
24. Kimura-Kuroda, J., and K. Yasui. 1988. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J. Immunol. 141:3606-3610.
25. Kimura-Kuroda, J., and K. Yasui. 1986. Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies. J. Gen. Virol. 67:2663-2672.
26. Kinney, R. M., and C. Y.-H. Huang. 2001. Development of new vaccines against dengue fever and Japanese encephalitis. Intervirology 44:176-197.
27. Konishi, E., A. Fujii, and P. W. Mason. 2001. Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles. J. Virol. 75:2204-2212.
28. Konishi, E., I. Kurane, P. W. Mason, R. E. Shope, N. Kanesa-Thasan, J. J. Smucny, C. H. Hoke, Jr., and F. A. Ennis. 1998. Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates. Vaccine 16:842-849.
29. Konishi, E., M. Yamaoka, Khin-Sane-Win, I. Kurane, and P. W. Mason. 1998. Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J. Virol. 72:4925-4930.
30. Konishi, E., and P. W. Mason. 1993. Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J. Virol. 67:1672-1675.
31. Konishi, E., S. Pincus, E. Paoletti, R. E. Shope, T. Burrage, and P. W. Mason. 1992. Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection. Virology 188:714-720.
32. Kurane, I. 2002. Immune responses to Japanese encephalitis virus. Curr. Top. Microbiol. Immunol. 267:91-103.
33. Lin, Y., C. Liao, C. Yeh, C. Chang, Y. Huang, Y. Huang, J. Jan, C. Chin, and L. Chen. 1996. A highly attenuated strain of Japanese encephalitis virus induces a protective immune response in mice. Virus Res. 44:45-56.
34. Lindenbach, B. D., and C. M. Rice. 2001. Flaviviridae: the viruses and their replication, p. 991-1041. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed., vol. 1. Lippincott Williams & Wilkins, Philadelphia, Pa.
35. Mackenzie, J. S., C. A. Johansen, S. A. Ritchie, A. F. Hurk, and R. A. Hall. 2002. Japanese encephalitis as an emerging virus: the emergence and spread of Japanese encephalitis virus in Australia. Curr. Top. Microbiol. Immunol. 267:49-74.
36. Mason, P. W., J. M. Dalrymple, M. K. Gentry, J. M. McCown, C. H. McCown, D. S. Burke, M. J. Fournier, and T. L. Mason. 1989. Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J. Gen. Virol. 70:2037-2049.
37. Monash, T. P. 2002. Japanese encephalitis vaccines: current vaccines and future prospects. Curr. Top. Microbiol. Immunol. 267:105-138.
38. Monath, T. P., I. Levenbook, K. Soike, Z. X. Zhang, M. Ratterree, K. Draper, A. D. Barrett, R. Nichols, R. Weltzin, J. Arroyo, and F. Guirakhoo. 2000. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J. Virol. 74:1742-1751.
39. Morita, K., M. Tadano, S. Nakaji, K. Kosai, E. G. Mathenge, B. D. Pandey, F. Hasebe, S. Inoue, and A. Igarashi. 2001. Locus of a virus neutralization epitope on the Japanese encephalitis virus envelope protein determined by use of long PCR-based region-specific random mutagenesis. Virology 287:417-426.
40. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-200.
41. Ramboug, A., and Y. Clermont. 1997. Three-dimensional structure of the Golgi apparatus in mammalian cells, p. 37-62. In E. G. Berger and J. Roth (ed.), The Golgi apparatus. Birkhäuser Verlag, Basel, Switzerland.
42. Roehrig, J. T., M. Layton, P. Smith, G. L. Campbell, R. Nasci, and R. S. Lanciotti. 2002. The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance. Curr. Top. Microbiol. Immunol. 267:223-240.
43. Sasaki, T., R. Harasawa, M. Shintani, H. Fujiwara, Y. Sasaki, A. Horino, T. Kenri, K. Asada, I. Kato, and F. Chino. 1996. Application of PCR for detection of mycoplasma DNA and pestivirus RNA in human live viral vaccines. Biologicals 24:371-375.
44. Sato, T., C. Takamura, A. Yasuda, M. Miyamoto, K. Kamogawa, and K. Yasui. 1993. High-level expression of the Japanese encephalitis virus E protein by recombinant vaccinia virus and enhancement of its extracellular release by NS3 gene product. Virology 192:483-490.
45. Schalich, J., S. L. Allison, K. Stiasny, C. W. Mandl, C. Kunz, and F. X. Heinz. 1996. Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J. Virol. 70:4549-4557.
46. Srqivastava, A. K., J. R. Putnak, S. H. Lee, S. P. Hong, S. B. Moon, D. A. Barvir, B. Zhao, R. A. Olson, S. Kim, W. Yoo, A. C. Towle, D. W. Vaughn, B. L. Innis, and K. H. Eckels. 2001. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells. Vaccine 19:4557-4565.
47. Stocks, C. E., and M. Lobigs. 1998. Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM. J. Virol. 72:2141-2149.
48. Tsai, T. F. 2000. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998. Vaccine 18:1-25.
49. World Health Organization. 1998. Requirements for the use of animal cells as in vitro substrates for the production of biologicals, p. 19-52. In WHO expert committee on biological standardization. WHO Technical Report Series, no. 878. World Health Organization, Geneva, Switzerland.
50. Yasuda, A., J. Kimura-Kuroda, M. Ogimoto, M. Miyamoto, T. Sata, T. Sato, C. Takamura, T. Kurata, A. Kojima, and K. Yasui. 1990. Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express prM and E glycoproteins of Japanese encephalitis virus. J. Virol. 64:2788-2795.